Publications

5674 Results

A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma in Persons of African Ancestry (African-American Multiple Myeloma Study (AAMMS)) Identifies Suggestive Risk Variants

Authors
Z Du;K Rand;C Song;N Weinhold;A Huang;X Sheng;D Van Den Berg;A Nooka;S Ailawadhi;S Singhal;E Peters;K Pawlish;N Janakiraman;H Terebelo;C Bock;A Morbacher;M Tomasson;M Fiala;J Mehta;R Kittles;B Rybicki;JL Stanford;P Goodman;S Berndt;J Carpten;V Horn;A Stram;G Casey;L Chu;W Diver;A Hennis;EM John;E Klein;R Orlowski;D Conti;C Haiman;W Cozen
Journal / Conference
American Society of Hematology, poster, abst. 3058A
Year
2017
Research Committee(s)
Cancer Control, Myeloma, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas

Authors
S Islam;W Qi;L Cook;C Spier;W Weterings;D Mahadevan
Journal / Conference
Molecular Cancer Therapeutics Oct;16(10):2083-2093; Epub 2017 Jun 14.
Year
2017
Research Committee(s)
Lymphoma
PMID
PMID28615297
PMC
PMC6574129
Study Number(s)
S0515

Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: A novel therapeutic strategy

Authors
S Islam;E Vick;B Huber;C Morales;C Spier;L Cooke;E Weterings;D Mahadevan
Journal / Conference
Oncotarget Nov 1;8(59):100326-100338; eCollection 2017 Nov 21.
Year
2017
Research Committee(s)
Lymphoma
PMID
PMID29245981
PMC
PMC5725023
Study Number(s)
S1108

High frequency of brain metastases after adjuvant therapy for high-risk melanoma

Authors
W Samlowski;J Moon;M Witter;MB Atkins;J Kirkwood;M Othus;A Ribas;V Sondak;L Flaherty
Journal / Conference
Cancer Medicine Nov;6(11):2576-2585
Year
2017
Research Committee(s)
Melanoma
PMID
PMID28994212
PMC
PMC5673911
Study Number(s)
S0008

Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients

Authors
M Lambertini;H Moore;RCF Leonard;S Loibl;P Munster;M Bruzzone;L Boni;J Unger;RA Anderson;K Mehta;S Minton;S Poggio;K Albain;DJA Adamson;B Gerber;A Cripps;G Bertelli;S Seiler;M Creppi;AH Partridge;L Del Mastro
Journal / Conference
San Antonio Breast Cancer Symposium abst. #GS4-01, oral presenation
Year
2017
Research Committee(s)
Breast and Cancer Survivorship
Study Number(s)
S0230

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry

Authors
D Conti;K Wang;X Sheng;J Bensen;D Hazelett;MB Cook;A Hsing;P Goodman;IM Thompson;EA Klein;BE Henderson;C Haiman
Journal / Conference
Journal of the National Cancer Institute Aug 1;109(8)
Year
2017
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID29117387
PMC
PMC5448553
Study Number(s)
S0000, SWOG-9217

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men

Authors
E Watts;P Appleby;D Albanes;A Black;JM Chan;C Chen;P Goodman;JK Parsons;EA Platz;JM Schenk Kisser;IM Thompson;T Key
Journal / Conference
PLoS One Dec 27;12(12):e0187741
Year
2017
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID29281666
PMC
PMC5744924
Study Number(s)
S0000, SWOG-9217

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Authors
C Fuchs;D Niedzwiecki;H Mamon;J Tepper;X Ye;R Swanson;P Enzinger;D Haller;T Dragovich;S Alberts;G Bjarnason;C Willett;L Gunderson;R Goldberg;A Venook;D Ilson;E O'Reilly;K Ciombor;D Berg;J Meyerhardt;R Mayer
Journal / Conference
Journal of Clinical Oncology Nov 10;35(32):3671-3677
Year
2017
Research Committee(s)
Gastrointestinal
PMID
PMID28976791
PMC
PMC5678342

Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107

Authors
P Twardowski;C Tangen;X Wu;MR Plets;ER Plimack;N Agarwal;NJ Vogelzang;J Wang;J Wang;S Tao;I Thompson;P Lara
Journal / Conference
Kidney Cancer Nov 27;1(2):123-132
Year
2017
Research Committee(s)
Genitourinary
PMID
PMID30334014
PMC
PMC6179121
Study Number(s)
S1107

History of diabetes and outcome among participants 65 or older in SWOG clinical trials

Authors
DL Hershman;C Till;JD Wright;S Ramsey;W Barlow;J Unger
Journal / Conference
JCO Clinical Cancer Informatics Nov;1:1-12; DOI: https://doi.org/10.1200/CCI.17.00040 Publishedonlineonascopubs.org/journal/ccion November 20, 2017.
Year
2017
Research Committee(s)
Breast, Gastrointestinal, Genitourinary, Lung, Myeloma, and Sarcoma
PMID
PMID30657402
PMC
PMC6640843
Study Number(s)
S0003, S0023, S0033, S0124, S0205, S0221, S0226, S0232, S0307, S0421, S0500, S0777, SWOG-9321, SWOG-9346, S9916